Retrophin (RTRX) Reports Q1 Loss of $0.04/Share

Go back to Retrophin (RTRX) Reports Q1 Loss of $0.04/Share

Retrophin Reports First Quarter 2015 Financial Results

May 11, 2015 4:06 PM EDT

First quarter revenues increased 23% sequentially to $17.4 million

Cholbam received FDA approval; launch underway

SAN DIEGO--(BUSINESS WIRE)-- Retrophin, Inc. (NASDAQ: RTRX) today reported its first quarter 2015 financial results.

Net product sales for the first quarter 2015 were $17.4 million Non-GAAP operating income for the first quarter 2015 was $1.4 million, compared to a non-GAAP operating loss of $17.5 million for the same period in 2014 Cash, cash equivalents and marketable securities as of March 31, 2015 totaled $126.3 million... More